List of works - Pau Montesinos

A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial

scientific article published on 05 February 2020

Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study.

scientific article published on 9 April 2018

Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype

scientific article published on 03 April 2020

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

scientific article published on 28 January 2015

Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience.

scientific article published on 9 May 2016

Central nervous system involvement at first relapse in patients with acute myeloid leukemia ⬇️

scientific article published on May 12, 2011

Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome-Negative Adult Lymphoblastic Leukemia

scientific article published on 04 November 2020

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

scientific article published on 11 December 2018

Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus

scientific article published on 01 March 2020

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

scientific article published on 06 February 2019

Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia

scientific article published on 18 July 2020

Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

scientific article published on 19 October 2020

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

scientific article published on 14 October 2020

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia ⬇️

scientific article published on May 3, 2011

Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation

scientific article published on 25 September 2020

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

scientific article published on 01 April 2018

IDH1-mutated relapsed or refractory AML: current challenges and future prospects

scientific article published on 27 June 2019

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

scientific article published on 02 November 2020

Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity

scientific article published on 18 February 2020

Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group

article

Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis

scientific article published on 25 June 2019

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

scientific article published on 04 March 2020

Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia

scientific article published on 27 May 2021

No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group

scientific article published in 2022

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

scientific article published on 19 February 2020

Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy

scientific article published on 26 February 2020

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

scientific article published on 02 July 2018

Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?

scientific article published on 17 September 2020

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis ⬇️

scientific article published on December 29, 2010

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

scientific article published on 16 December 2018

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

scientific article published on 24 August 2017

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

scientific article published on 09 May 2019

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

scientific article published on 16 March 2020

Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review

scientific article published on 24 September 2020

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients

scientific article published on 27 March 2019

Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus

scientific article published on 30 October 2019

Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients

scientific article published on 08 March 2019

List of works by Pau Montesinos